NeoGenomics
$26.629876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$26.62
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.55 (+2.11%) Today
$0.00 (0.00%) As of 8:00 PM EST after-hours
Why Robinhood?
You can buy or sell NeoGenomics and other stocks, options, ETFs, and crypto commission-free!
About NEO
NeoGenomics, Inc. Common Stock, also called NeoGenomics, is a clinical laboratory, which specializes in cancer genetics diagnostic testing and pharma services. Read More It operates through the following two segments: Clinical and Pharma Services. The Clinical Services segment offers clinical cancer testing services to community-based pathologists. The Pharma Services segments supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. The Clinical Services Segment provides various clinical testing services to community-based pathology practices, hospital pathology labs and academic centers with reimbursement from various payers including client direct billing, commercial insurance, Medicare and other government payers, and patients. The Pharma Services segment: provides comprehensive testing services in supports pharmaceutical clients' oncology programs from discovery to commercialization. Its services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology and molecular genetic testing. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.
Employees
1,500
Headquarters
Fort Myers, Florida
Founded
1998
Market Cap
2.72B
Price-Earnings Ratio
1.49K
Dividend Yield
0.00
Average Volume
620.22K
High Today
$26.88
Low Today
$26.13
Open Price
$26.40
Volume
836.48K
52 Week High
$26.88
52 Week Low
$11.05
Collections
Analyst Ratings
100%
of 8 ratings
Buy
100%
Hold
0%
Sell
0%
NEO Earnings
$0.02
$0.04
$0.05
$0.07
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
—
Actual
Expected Feb 18, Pre-Market